I’ve been looking into some upcoming trials for new cardiac devices and noticed several protocols focus heavily on patient selection criteria. It’s interesting how different institutions adapt certain tech specs, and wondering if anyone else has insights on the challenges faced during those initial phases of trial design. What have your experiences been like with similar trials?
It’s true that patient selection criteria can make or break a trial. We’ve faced challenges with tech specs that differ widely between institutions; it’s crucial to have a strong consensus on those parameters early on. I’ve found that running preliminary workshops with all stakeholders really helps streamline those discussions — might be worth considering in your planning. @mentioning others in your network for this could also yield some valuable insights.
, the patient selection criteria can get really tricky. I remember a trial we ran where institutional differences led to a major headache with the tech specs — we had to pivot mid-study to accommodate. It’s crucial to have those standards aligned from the get-go.